000			01706 a2200469 4500
005			20250513204929.0
264		0	_c20000802
008			200008s 0 0 eng d
022			_a0305-7232
040			_aNLM _beng _cNLM
100	1		_aJankun, J
245	0	0	_aMolecular basis of specific inhibition of urokinase plasminogen activator by amiloride. _h[electronic resource]
260			_bCancer biochemistry biophysics _cJul 1999
300			_a109-23 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAmiloride _xchemistry
650	0	4	_aAmino Acid Chloromethyl Ketones _xchemistry
650	0	4	_aAmino Acid Sequence
650	0	4	_aAntineoplastic Agents _xchemistry
650	0	4	_aBinding Sites _xdrug effects
650	0	4	_aBinding, Competitive
650	0	4	_aCatalysis _xdrug effects
650	0	4	_aCrystallography, X-Ray
650	0	4	_aDrug Design
650	0	4	_aHumans
650	0	4	_aModels, Molecular
650	0	4	_aMolecular Conformation
650	0	4	_aMolecular Sequence Data
650	0	4	_aNeoplasm Proteins _xantagonists & inhibitors
650	0	4	_aProtein Binding
650	0	4	_aProtein Conformation
650	0	4	_aProtein Structure, Tertiary
650	0	4	_aSequence Alignment
650	0	4	_aSequence Homology, Amino Acid
650	0	4	_aSerine Proteinase Inhibitors _xchemistry
650	0	4	_aSubstrate Specificity
650	0	4	_aTissue Plasminogen Activator _xchemistry
650	0	4	_aUrokinase-Type Plasminogen Activator _xantagonists & inhibitors
650	0	4	_aWater _xchemistry
700	1		_aSkrzypczak-Jankun, E
773	0		_tCancer biochemistry biophysics _gvol. 17 _gno. 1-2 _gp. 109-23
999			_c10692389 _d10692389